The prognostic value of the lysyl oxidase family in ovarian cancer.

Miaomiao YeJunhan ZhouYing GaoShuya PanXueqiong Zhu

Published in: Journal of clinical laboratory analysis (2020)

LOX, LOXL1, LOXL2, and LOXL3 may become potential predictive markers for negative outcomes in OC patients. Moreover, the LOX family can serve as new molecular predictors for the efficiency of platinum-based chemotherapy in OC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
type diabetes
metabolic syndrome
risk assessment
radiation therapy
patient reported outcomes
insulin resistance
climate change